Ebola virus vaccine - GenPhar
Latest Information Update: 25 Nov 2021
Price :
$50 *
At a glance
- Originator GenPhar
- Class Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Ebola virus infections
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Ebola-virus-infections in USA (Parenteral)
- 21 Mar 2007 Clinical trials in Ebola virus infections in USA (Parenteral)
- 23 Oct 2002 Preclinical trials in Ebola virus infections in USA (Parenteral)